Prosecution Insights
Last updated: October 02, 2026

Examiner: FARDANESH, MARJAN

Tech Center 3700 • Art Units: 3735 3777 3791 3792

This examiner grants 73% of resolved cases

Analysis

Marjan Fardanesh is an examiner in Tech Center 3700 and Art Unit 3735, with 876 resolved cases. Her allowance rate of 72.6% indicates a favorable success rate for patent applications. The median days to allowance is 1231, which provides a clear expectation for the time required to reach a final decision.

The interview lift of 18.9% is a significant metric, suggesting that interviews are highly effective at increasing the 72.6% allowance rate. For those practicing in Art Unit 3735, this 18.9% lift is a valuable tool for resolving outstanding issues. The 876 resolved cases offer a stable foundation for these performance metrics.

With a median days to allowance of 1231, Fardanesh maintains a pace that applicants should factor into their long-term planning. The combination of a solid allowance rate and a high interview lift suggests a receptive environment in Tech Center 3700. Practitioners should leverage the 18.9% lift to navigate the 1231-day timeline.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

72.6%
Allow Rate
+2.6% vs TC avg
896
Total Applications
+18.9%
Interview Lift
1231
Avg Prosecution Days
Based on 876 resolved cases, 2023–2026

Rejection Statute Breakdown

9.8%
§101 Eligibility
23.3%
§102 Novelty
29.8%
§103 Obviousness
24.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17858505 VITAL SIGN MEASUREMENT DEVICE Final Rejection SUBARU CORPORATION
18987112 GLUCOSE OXIDASE SENSORS WITH IMPROVED STABILITY Non-Final OA Abbott Diabetes Care, Inc.
18993313 SENSOR MOUNT WITH EMBEDDED CONDUCTORS FOR DIFFERENT SENSOR Non-Final OA KONINKLIJKE PHILIPS N.V.
19036983 METHOD AND AN ANALYTE SENSOR SYSTEM FOR DETECTING AT LEAST ONE ANALYTE Non-Final OA Roche Diabetes Care, Inc.
18495691 SYSTEM AND METHOD FOR AUTOREGULATION DATA DETERMINATION Non-Final OA EDWARDS LIFESCIENCES CORPORATION
18932601 Compute Core Capsule Device for Processing Biopotential Signals Detected by a Wearable Device, Including a Dual-Purpose Electrical Base Plate, and Methods of Manufacturing Thereof Non-Final OA Meta Platforms Technologies, LLC
18987455 Articulation member for or in a deflection mechanism Non-Final OA KARL STORZ SE & Co. KG
18979259 TOTAL HEMOGLOBIN SCREENING SENSOR Non-Final OA Masimo Corporation
18667442 PHYSIOLOGICAL MEASUREMENT DEVICE Non-Final OA Masimo Corporation
18595899 APPARATUS AND METHOD FOR CREATING A STABLE OPTICAL INTERFACE Non-Final OA Masimo Corporation
18854610 Arterial Blood Gas Syringe Non-Final OA Becton, Dickinson and Company
18869050 LIQUID SAMPLER FOR FAST CAPTURE OF INITIAL VOLUME OF A LIQUID FLOW Non-Final OA DNA GENOTEK INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month